Regarding the 'High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy'

Liver Int. 2025 Jan;45(1):e16105. doi: 10.1111/liv.16105.
No abstract available

Publication types

  • Letter